When is the optimal time to perform thymectomy in a patient with myasthenia gravis (MG) who is considering Total Plasma Exchange (TPE) preoperative thymectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of TPE Before Thymectomy in Myasthenia Gravis

Total Plasma Exchange (TPE) should be performed 10-30 days before thymectomy, consisting of 5 sessions conducted every other day, with each session exchanging 200-250 mL plasma/kg body weight or 1-L exchanges using fresh-frozen plasma or 5% albumin. 1

Preoperative Optimization Protocol

Medical Control Must Be Achieved First

Medical control of myasthenia gravis is mandatory before any surgical procedure, including thymectomy 1, 2. This is critical because approximately 20% of thymoma-related mortality is directly attributable to myasthenia gravis complications rather than the tumor itself 2.

TPE Protocol Specifications

The standard TPE protocol involves:

  • 5 sessions total, performed every other day 1
  • Volume: 200-250 mL plasma/kg body weight or 1-L exchanges per session 1
  • Replacement fluid: Fresh-frozen plasma or 5% albumin, exchanging twice the blood volume 1
  • Timing window: 10-30 days before the scheduled surgery 1

Alternative: IVIG May Be Preferred

IVIG is increasingly favored over TPE as first-line preoperative therapy due to easier administration, wider availability, and fewer complications 1. The IVIG protocol consists of 0.4 g/kg/day for 5 consecutive days (total dose 2 g/kg) 1.

Patient Selection for Preoperative TPE/IVIG

High-Risk Patients Requiring Preoperative Treatment

Patients with the following features should receive preoperative IVIG or TPE 1:

  • Dysphagia 1
  • Notable weight loss 1
  • Severe generalized weakness 1
  • Respiratory compromise (vital capacity <20 mL/kg, maximum inspiratory pressure <30 cm H2O, or maximum expiratory pressure <40 cm H2O) 1

Mandatory Preoperative Assessment

Before thymectomy, all patients must undergo 1, 3:

  • Comprehensive respiratory assessment with negative inspiratory force (NIF) and vital capacity (VC) measurements 1
  • Serum anti-acetylcholine receptor antibody levels 1, 2
  • Cardiac evaluation with ECG and echocardiogram if respiratory failure or elevated CPK levels present 1
  • Neurologist consultation and treatment optimization 2

Critical Pitfalls to Avoid

IgA Deficiency Screening

Check serum IgA levels before administering IVIG, as IgA deficiency may lead to severe anaphylaxis 1. This is a potentially fatal complication that is entirely preventable with proper screening.

Timing Considerations

The 10-30 day window allows sufficient time for:

  • Clinical improvement to manifest 1
  • Antibody levels to decrease (though clinical benefit does not require antibody reduction) 4
  • Optimization of respiratory function before anesthesia 3

Perioperative Medication Management

Continue anticholinesterase medications (pyridostigmine) perioperatively unless contraindicated 1. However, patients on immunosuppression therapy are more prone to complications 5, so careful monitoring is essential.

Postoperative Monitoring

Close monitoring for myasthenic crisis is essential postoperatively, including respiratory failure surveillance 1. Consider early tracheostomy in high-risk patients, particularly those unable to lift arms from bed at 1 week after intubation 1.

References

Guideline

Preoperative Management of Myasthenia Gravis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Thymus-Related Autoimmunity in Myasthenia Gravis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Preoperative preparation and anesthetic management of patients with myasthenia gravis.

Seminars in thoracic and cardiovascular surgery, 1999

Research

Transsternal thymectomy for myasthenia gravis: surgical outcome.

The Annals of thoracic surgery, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.